Emerson builds strategic relationship to accelerate life sciences product pipelines

syncade-esp-release

Emerson has selected Enterprise System Partners (ESP), a global consulting and project engineering company, to collaborate with and assist life sciences manufacturers in implementing Syncade manufacturing execution systems to improve operations management and accelerate product manufacturing pipelines for new biotech and pharmaceutical therapies.

By understanding the unique challenges of MES projects, Emerson and ESP have completely refreshed their execution model and methodology. Now the team deploys an iterative approach to project delivery that enables life science enterprises to adopt new technology faster — and start up more rapidly. Faster, iterative approaches will help ensure projects reflect the project vision and end-user requirements, while helping Emerson and ESP meet increased demand for its Syncade MES.

“Being successful in a growing industry like life sciences requires new and innovative approaches to execute projects. In selecting ESP to collaborate, we have set the stage for even more efficient project execution,” says Tom Snead, president of global life sciences industry for Emerson. “As life sciences manufacturers are pressured to bring medicines to patients sooner, we provide a path to keep pace with patient and market needs.”

The new model is a change from the industry’s traditional waterfall execution approach and will streamline the process, reduce risk, and minimize rework and cost.

“ESP’s business has been about best-in-class project delivery of MES solutions to the life science industry for the last 15 years.  We are delighted to share that expertise with Emerson for the application of their world-class industry products,” says Liam O’Brien, managing director, ESP. “The synergy that exists between our two companies in understanding the complexities of MES projects provides our clients with innovative solutions to increase efficiency and avail of advanced work methodologies.”